Seller record · Telehealth service

AVArx

Fails 3 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The answers and the shipping policy refer only to independent, licensed U.S. pharmacy partners. 2 more criteria also fail; see the table below.

At a glance

AVArxTelehealth service

5/8criteria passed
Price
GLP-1 care from $199
Sells
compounded semaglutide injections, compounded tirzepatide injections, and 5 more
FDA letters
None on file
Visit AVArxSee all eight dispositions

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A Glendale, California telehealth platform that connects patients with an affiliated medical group for compounded semaglutide and tirzepatide after an online questionnaire, and also offers sermorelin injections and troches, NAD+ injections and nasal spray, and glutathione.

Operating entity AVArx LLC

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSAVArx's website; AVArx's terms
S2Prescription gatingPASSAVArx's website; AVArx's semaglutide product page
S3Pharmacy identificationFAILAVArx's website; AVArx's shipping page
S4Compounding disclosureFAILAVArx's online GLP-1 weight loss care page; AVArx's semaglutide product page; AVArx's tirzepatide product page
S5Analytical documentationFAILAVArx's treatments page; AVArx's website; AVArx's terms
S6Business addressPASSAVArx's contact page; AVArx's terms
S7Price disclosurePASSAVArx's online GLP-1 weight loss care page; AVArx's treatments page
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA U.S.-licensed provider reviews each questionnaire and decides whether treatment is appropriate, and the answers and terms name Arora Health & Aesthetics, LLC as the medical group whose providers deliver the care.Source: AVArx's website; AVArx's terms.
S2PASSThe steps list a free five-minute medical questionnaire first, then a provider review, then delivery, and the home page says the plan total is shown before checkout.Source: AVArx's website; AVArx's semaglutide product page.
S3FAILNo filling pharmacy is named. The answers and the shipping policy refer only to independent, licensed U.S. pharmacy partners.Source: AVArx's website; AVArx's shipping page.
S4FAILThe online GLP-1 care page says compounded semaglutide or tirzepatide may be dispensed, but no page states that compounded drugs are not FDA-approved.Source: AVArx's online GLP-1 weight loss care page; AVArx's semaglutide product page; AVArx's tirzepatide product page.
S5FAILNo certificate of analysis or lot document is published on the treatment pages, the answers or the terms.Source: AVArx's treatments page; AVArx's website; AVArx's terms.
S6PASSAVArx LLC at 6034 San Fernando Rd, Glendale, CA 91202, printed as the mailing address on the contact page and in the terms, privacy policy and shipping policy. The terms name California law.Source: AVArx's contact page; AVArx's terms.
S7PASSGLP-1 care from $199, printed beside the compounded semaglutide and tirzepatide on the online care page. No other price is printed, and the sermorelin, NAD+ and glutathione pages carry none.Source: AVArx's online GLP-1 weight loss care page; AVArx's treatments page.
S8PASSNo FDA warning letter names AVArx or AVArx LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide injections, compounded tirzepatide injections, sermorelin, sermorelin troches, NAD+ injection, NAD+ nasal spray, glutathione.

Visit AVArx

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.